Sight Sciences, (id:7991 SGHT)
3.76 USD
Opening hours: 09:30 - 16:00 (Eastern Standard Time: 11/22/2024 7:13:16 AM)
Exchange closed, opens in 2 hours 16 minutes
About Sight Sciences,
Market Capitalization 194.54M
Sight Sciences, Inc., an ophthalmic medical device company, engages in the development and commercialization of surgical and nonsurgical technologies for the treatment of eye diseases. It operates through two segments, Surgical Glaucoma and Dry Eye. The company's products include OMNI Surgical System, an implant-free glaucoma surgery technology indicated to reduce intraocular pressure in adult patients with primary open-angle glaucoma; and SION Surgical Instrument, a manually operated device used in ophthalmic surgical procedures to excise trabecular meshwork. It also offers TearCare System, a wearable eyelid technology for adult patients with evaporative dry eye disease due to meibomian gland dysfunction, as well as related components. It offers its products through sales representatives and distributors to hospitals, medical centers, and eyecare professionals in the United States. Sight Sciences, Inc. was incorporated in 2010 and is headquartered in Menlo Park, California.
| Headquarters (address) |
4040 Campbell Avenue Menlo Park 94025 CA United States |
| Phone | 877 266 1144 |
| Website | https://www.sightsciences.com |
| Employees | 214 |
| Sector | Healthcare |
| Industry | Medical Devices |
| Ticker | SGHT |
| Exchange | NASDAQ Stock Exchange |
| Currency | USD |
| 52 week range | 2.58 - 8.45 |
| Market Capitalization | 194.54M |
| P/E trailing | -3.27 |
| P/E forward | -4.69 |
| Price/Sale | 2.45 |
| Price/Book | 2.02 |
| Beta | 2.73 |
| EPS | -0.990 |
| EPS United States (ID:6, base:3395) | 24.30 |